Proactive's Robin Davison publishes fresh research note on Poolbeg PharmaMarch 09, 2023 at 07:53 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
--News Direct--  Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001. Contact DetailsProactive UK Ltd +44 20 7989 0813 View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know. Report this articleMore NewsView More
CorVel Q4 Earnings Call Highlights ↗
Today 14:04 EDT
TJX Companies Q1 Earnings Call Highlights ↗
Today 14:04 EDT
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||
